FA-HP-β-CyD also exhibited antileukemic activity in acute myeloid leukemia cells via autophagic cell death and showed synergistic activity with venetoclax, a BCL-2 inhibitor [204]. This evidence concerns the gene BCL2 and acute myeloid leukemia.